Full history for every metric is available with a Kvantra account
Ovoca Bio plc (OVB.L)
Key financial summary
Financials in EUR| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating profit | €m | -0 | - | |||||
| Net profit | €m | -2 | -2 | -5 | -6 | -5 | -1 | - |
| EPS reported | € | 0.00 | - | |||||
| Operating cashflow per share | € | -0.01 | 0.00 | |||||
| Capex per share | € | 0.00 | 0.00 | |||||
| FCF per share | € | -0.01 | 0.00 | |||||
| Free cash flow | €m | -1 | -12,082 | |||||
| Net debt | €m | -3 | -3 | |||||
| Book value equity | €m | 2 | 2 | |||||
| Book value per share | € | 0.03 | 0.02 | |||||
| Number of shares | m | 81.56 | 92.84 | |||||
| DPS (TTM paid) | € | 0.00 | 0.00 |
Financial summary
Financials in EUR| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 2.30 | 1.22 | |||||
| P/S LTM | x | 0.00 | 0.00 | |||||
| P/FCF LTM | x | -4.16 | -0.00 | |||||
| EV/EBITDA LTM | x | 43.61 | 0.02 | |||||
| EV/Sales LTM | x | 0.00 | 0.00 | |||||
| Earnings Yield LTM | % | -15.77% | 0.00% | |||||
| FCF Yield | % | -24.02% | -479448.8% | |||||
| Quality | ||||||||
| ROE | % | -36.21% | 0.00% | |||||
| ROIC | % | -0.15% | 0.00% | |||||
| Operating margin | % | 0.00% | 0.00% | |||||
| Gross margin | % | 0.00% | 0.00% | |||||
| FCF/Sales | % | - | - | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | - | - | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | - | - | |||||
| Net Debt/EBITDA | x | -49.14 | 0.00 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -52.98% | -99.45% | |||||
| Net debt/Equity | x | -1.22 | -1.22 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Based in Dublin, Ireland, Ovoca Bio plc is a biopharmaceutical firm specializing in clinical-stage research and development. Founded in 1985, the company is dedicated to creating and commercializing novel therapeutic solutions for various female sexual dysfunctions. Its flagship product candidate, BP-101, is being developed as a medical intervention for premenopausal women experiencing hypoactive sexual desire disorder. BP-101 is currently in Phase II clinical trials across Australia and New Zealand, with Phase III trials concurrently underway in Russia. Additionally, the company maintains involvement in mineral exploration activities and provides support services. Originally incorporated as Ovoca Gold plc, the company rebranded to Ovoca Bio plc in July 2018.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Ovoca Bio plc (OVB.L)
Based in Dublin, Ireland, Ovoca Bio plc is a biopharmaceutical firm specializing in clinical-stage research and development. Founded in 1985, the company is dedicated to creating and commercializing novel therapeutic solutions for various female sexual dysfunctions. Its flagship product candidate, BP-101, is being developed as a medical intervention for premenopausal women experiencing hypoactive sexual desire disorder. BP-101 is currently in Phase II clinical trials across Australia and New Zealand, with Phase III trials concurrently underway in Russia. Additionally, the company maintains involvement in mineral exploration activities and provides support services. Originally incorporated as Ovoca Gold plc, the company rebranded to Ovoca Bio plc in July 2018.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free